We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Sekisui Diagnostics UK Ltd.

Physio-Control

Physio-Control develops, manufactures, sells and services external defibrillator/monitors and emergency medical respo... read more Featured Products: More products

Download Mobile App




First Closed-Heart Surgery Using a Nitinol Stent

By HospiMedica International staff writers
Posted on 09 Apr 2014
Print article
Image: The 3f Aortic Bioprosthesis (Photo courtesy of Medtronic).
Image: The 3f Aortic Bioprosthesis (Photo courtesy of Medtronic).
The first totally endoscopic aortic valve replacement (TEAVR) has been performed on two patients in France.

Researchers at the Centre Hospitalier Universitaire de Saint-Étienne (France) have reported the first successful TEAVR procedure, which has not been feasible previously because of the currently available designs of stented tissue valves. The two patients, aged 82 and 93 years of age, suffered from aortic valve stenosis. In all, the patients spent about two and a half hours under cardiopulmonary bypass, but the actual implantation of the device took only 45 minutes. Both patients were discharged from the hospital in a week and have had no serious complications since.

The new procedure may enable surgeons to replace the aortic valve without opening the chest, though it will still require cardiopulmonary bypass and excision of the old valve. The key to the new procedure is the recent availability of sutureless aortic valve bioprostheses, in this case the 3f Enable bioprosthesis, which is mounted on a compressible self-expanding nitinol stent. Sutureless substitutes are not yet available for the other cardiac valves, such as the mitral valve. The study describing the new procedure was published in the March 2014 issue of Journal of Thoracic and Cardiovascular Surgery.

“These first procedures show that totally endoscopic sutureless aortic valve replacement is technically feasible,” said lead surgeon Marco Vola, MD. “It is important to note that when performing TEAVR, a quick and safe conversion to minithoracotomy under direct view can be made if circumstances demand. This would still offer significantly reduced chest trauma.”

The 3f Aortic Bioprosthesis, a product of Medtronic (Minneapolis, MN, USA), is composed of three equine pericardial leaflets, shaped in the form of a tube, which collapse in response to pressure, reproducing the functional characteristics of a native aortic valve. The design preserves aortic sinuses by maintaining continuity between the annulus and the sinotubular junction, without the need for a second suture line. The greatest stress is toward the semilunar “belly” of the cusps, as observed in healthy aortic valves.

The aortic valve is the outlet valve from the left ventricle and usually requires repair or replacement when it either does not open completely, or does not close properly, and therefore blood leaks back into the left ventricle. The symptoms most often associated with aortic valve disease are shortness of breath, chest pain, fatigue, arrhythmias, palpitations, and syncope usually associated with exertion.

Related Links:

Centre Hospitalier Universitaire de Saint-Étienne
Medtronic


Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
12-Channel ECG
CM1200B
Silver Member
Compact 14-Day Uninterrupted Holter ECG
NR-314P
New
Neonatal Transport Ventilator
Babylite

Print article

Channels

Surgical Techniques

view channel
Image: Lightning Flash 2.0 features advanced computer assisted vacuum thrombectomy software (Photo courtesy of Penumbra)

Next-Gen Computer Assisted Vacuum Thrombectomy Technology Rapidly Removes Blood Clots

Pulmonary embolism (PE) occurs when a blood clot blocks one of the arteries in the lungs. Often, these clots originate from the leg or another part of the body, a condition known as deep vein thrombosis,... Read more

Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)

Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing

Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.